The efficacy and toxicity of mycophenolate mofetil (MMF) are concentration-dependent, yet a standard fixed dose of 2 g/day is currently recommended for maintenance immunosuppression in adult renal ...

Preddie et al. have investigated whether the immunosuppressant mycophenolate mofetil (MMF) could be useful in such patients. The study included eight patients with biopsy-proven AIN who had ...

† One patient had MMF as an initial treatment. ‡ In the study TAC and MMF were used alone or in combination. §In total, 17 patients were initially treated with MMF and steroids. ¶ Females ...

Relapse is common among patients with systemic polyarteritis nodosa, with mycophenolate performing similarly to cyclophosphamide.